Download presentation
1
ACUTE INFLAMMATION
2
ACUTE INFLAMMATION COMPONENT
Definition: Acute inflammation is a rapid response to an injurious agent that serves to deliver mediators of host defense-leukocytes and plasma proteins-to the site of injury. Acute inflammation has three major components: (1) alterations in vascular caliber that lead to an increase in blood flow; (2) structural changes in the microvasculature that permit plasma proteins and leukocytes to leave the circulation; (3) emigration of the leukocytes from the microcirculation, their accumulation in the focus of injury, and their activation to eliminate the offending agent. (Robbins, 7th ed.) When a host encounters an injurious agent, such as an infectious microbe or dead cells, phagocytes that reside in all tissues try to get rid of these agents. At the same time, phagocytes and other host cells react to the presence of the foreign or abnormal substance by liberating cytokines, lipid messengers, and the various other mediators of inflammation.
3
PLASMA PROTIEN & ACUTE INFLAMMATION
Plasma proteins leave the vessels, most commonly through widened interendothelial cell junctions of the venules. The redness (rubor), warmth (calor), and swelling (tumor) of acute inflammation are caused by the increased blood flow and edema. Circulating leukocytes, initially predominantly neutrophils, adhere to the endothelium via adhesion molecules, transmigrate across the endothelium, and migrate to the site of injury under the influence of chemotactic agents. Leukocytes that are activated by the offending agent and by endogenous mediators may release toxic metabolites and proteases extracellularly, causing tissue damage. During the damage, and in part as a result of the liberation of prostaglandins, neuropeptides, and cytokines, one of the local symptoms is pain (dolor).
4
Plasma proteins leave the vessels, most commonly through widened interendothelial cell junctions of the venules. The redness (rubor), warmth (calor), and swelling (tumor) of acute inflammation are caused by the increased blood flow and edema. Circulating leukocytes, initially predominantly neutrophils, adhere to the endothelium via adhesion molecules, transmigrate across the endothelium, and migrate to the site of injury under the influence of chemotactic agents. Leukocytes that are activated by the offending agent and by endogenous mediators may release toxic metabolites and proteases extracellularly, causing tissue damage. During the damage, and in part as a result of the liberation of prostaglandins, neuropeptides, and cytokines, one of the local symptoms is pain (dolor).
5
ACUTE INFLAMMATION Mediators Acute inflammation INJURY
6
ACUTE INFLAMMATION
7
ACUTE INFLAMMATION
8
ACUTE INFLAMMATION Vasoconstriction Vasodilation
SEQUENCE OF EVENTS Vasoconstriction Vasodilation Increased vascular permeability Hemoconcentration and stasis Leukocyte Adhesion Transmigration Chemotaxis Aggregation Phagocytosis
9
ACUTE INFLAMMATION VASODILATION
10
ACUTE INFLAMMATION VASODILATION
11
INCREASED VASCULAR PERMEABILITY
ACUTE INFLAMMATION INCREASED VASCULAR PERMEABILITY Increase in Permeability Histamine (Mast Cells) Seratonin (Platelets) Time
12
INCREASED VASCULAR PERMEABILITY
ACUTE INFLAMMATION INCREASED VASCULAR PERMEABILITY
13
HEMOCONCENTRATION AND STASIS
ACUTE INFLAMMATION HEMOCONCENTRATION AND STASIS Normal flow Stasis
14
ACUTE INFLAMMATION LEUKOCYTE ADHESION
15
ACUTE INFLAMMATION LEUKOCYTE ADHESION
16
EMIGRATION (TRANSMIGRATION)
ACUTE INFLAMMATION EMIGRATION (TRANSMIGRATION)
17
EMIGRATION (TRANSMIGRATION)
ACUTE INFLAMMATION EMIGRATION (TRANSMIGRATION)
18
ACUTE INFLAMMATION CHEMOTAXIS
19
ACUTE INFLAMMATION AGGREGATION
20
PHAGOCYTOSIS - ATTACHMENT
ACUTE INFLAMMATION PHAGOCYTOSIS - ATTACHMENT
21
PHAGOCYTOSIS - ENGULFMENT
ACUTE INFLAMMATION PHAGOCYTOSIS - ENGULFMENT
22
PHAGOCYTOSIS – KILLING AND DEGRADATION
ACUTE INFLAMMATION PHAGOCYTOSIS – KILLING AND DEGRADATION
23
ACUTE INFLAMMATION
24
ACUTE INFLAMMATION Serous Catarrhal Fibrinous Hemorrhagic Suppurative
PATTERNS Serous Catarrhal Fibrinous Hemorrhagic Suppurative Gangrenous Pseudomembranous
25
ACUTE INFLAMMATION SEROUS
26
ACUTE INFLAMMATION SEROUS
27
ACUTE INFLAMMATION CATARRHAL
28
ACUTE INFLAMMATION FIBRINOUS
29
SUPPURATIVE / PURULENT
ACUTE INFLAMMATION SUPPURATIVE / PURULENT
30
SUPPURATIVE / PURULENT - ABSCESS
ACUTE INFLAMMATION SUPPURATIVE / PURULENT - ABSCESS
31
SUPPURATIVE / PURULENT - ABSCESS
ACUTE INFLAMMATION SUPPURATIVE / PURULENT - ABSCESS
32
SUPPURATIVE / PURULENT - EMPYEMA
ACUTE INFLAMMATION SUPPURATIVE / PURULENT - EMPYEMA
33
ACUTE INFLAMMATION ULCERATIVE Ulcers of tularemia
34
ACUTE INFLAMMATION GANGRENOUS
35
ACUTE INFLAMMATION GANGRENOUS Appendix Gallbladder
36
ACUTE INFLAMMATION PSEUDOMEMBRANOUS
37
ACUTE INFLAMMATION Heat Redness Swelling Pain Loss of function
LOCAL MANIFESTATIONS Heat Redness Swelling Pain Loss of function
38
SYSTEMIC MANIFESTATIONS
ACUTE INFLAMMATION SYSTEMIC MANIFESTATIONS Fever Chills Myalgia Discomfort
39
LABORATORY MANIFESTATIONS
ACUTE INFLAMMATION LABORATORY MANIFESTATIONS Leukocytosis (granulocytosis vs. lymphocytosis) Elevated serum acute phase proteins (C-reactive protein, fibrinogen, etc) Increased ESR (erythrocyte sedimentation rate) Hypercoagulability
40
ACUTE INFLAMMATION SEQUELAE RESOLUTION Mediators Acute inflammation
INJURY Chronic irritation Mediators Mediators Viral infection Autoimmune disease Chronic inflammation
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.